An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy ; volume:14 ; number:1 ; day:2 ; month:11 ; year:2024 ; pages:1-16 ; date:12.2024
Scientific reports ; 14, Heft 1 (2.11.2024), 1-16, 12.2024
- Urheber
-
Naveed, Muhammad
Batool, Zainab
Aziz, Tariq
Javed, Khushbakht
Ali, Nouman
Rehman, Hafiz Muzzammel
Alharbi, Metab
Alasmari, Abdullah F.
Alshammari, Abdulrahman
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-77664-4
- URN
-
urn:nbn:de:101:1-2501212107183.171108229157
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Naveed, Muhammad
- Batool, Zainab
- Aziz, Tariq
- Javed, Khushbakht
- Ali, Nouman
- Rehman, Hafiz Muzzammel
- Alharbi, Metab
- Alasmari, Abdullah F.
- Alshammari, Abdulrahman
- SpringerLink (Online service)
Ähnliche Objekte (12)
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Key parameters of measles virus production for oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
Combining Oncolytic Virotherapy with Target Therapy in Bladder Cancer
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Key parameters of measles virus production for oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
Combining Oncolytic Virotherapy with Target Therapy in Bladder Cancer
Oncolytic virotherapy of glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Key parameters of measles virus production for oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy